The FDA has granted Lupin Pharmaceuticals approval for its zolpidem tartrate extended-release tablets in 6.25 mg and 12.5 mg strengths to treat insomnia. The treatment is a generic version of Sanofi Aventis' Ambien CR extended-release tablets.
FDA approves Lupin's generic insomnia treatment
SmartBrief Job Listings for Health Care
|Chief Operating Officer||
Presence Health Partners
|Des Plaines, IL|
|Sr. Business Systems Analyst||
|Sr. Reimbursement Analyst||
Olympus America Inc.
|Leadership Recruiting Manager||
|Strategic Partner Relationship Executive||
Geisinger Health System